DRI Healthcare Trust DHT-UN.TO
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · drihealthcare.com
DRI Healthcare Trust is a Toronto-headquartered trust focused on acquiring and managing a portfolio of pharmaceutical royalties, providing capital to biopharmaceutical innovators in exchange for royalty interests in marketed medicines. Its portfolio includes royalties on drugs such as Eylea, Orserdu, Spinraza, Vonjo and Zytiga. Its units trade on the Toronto Stock Exchange in Canadian dollars as DHT.UN and in U.S. dollars as DHT.U.
Key ratios
CashFromOperationsYoYGrowth TTM -0.27
CashFromOperationsYoYGrowth 2025 -0.29
CashFromOperationsYoYGrowth 2024 1.03
CashFromOperationsYoYGrowth 2023 -0.01
DilutedEPSYoYGrowth TTM -0.58
DilutedEPSYoYGrowth 2023 6.32
FreeCashFlowOnSale TTM 0.54
FreeCashFlowOnSale 2025 0.57
FreeCashFlowOnSale 2024 0.83
FreeCashFlowOnSale 2023 0.46
NetIncomeMargin 2025 -0.26
NetIncomeMargin 2024 -0.02
NetIncomeMargin 2023 0.55
ReturnOnAssets 2025 0.03
ReturnOnAssets 2024 0.03
ReturnOnAssets 2023 0.02
ReturnOnEquity TTM -0.1
ReturnOnEquity 2025 -0.1
ReturnOnEquity 2024 -0.01
ReturnOnEquity 2023 0.2
TotalRevenueYoYGrowth TTM 0.06
TotalRevenueYoYGrowth 2025 0.03
TotalRevenueYoYGrowth 2024 0.12
TotalRevenueYoYGrowth 2023 0.79
Recent news
DRI Healthcare Announces Exercise of Put Option on EKTERLY®
2026-07-10 · CNW